North China Pharmaceutical Group New Drug Research And Development Co., Ltd  

North China Pharmaceutical Group New Drug Research and Development Co., Ltd (NCPC R&D) is a subsidiary of North China Pharmaceutical Group Corporation (NCPC). Aiming at the discovery of novel drugs, NCPC R&D focuses primarily on the research and development of biological products and pharmaceutical chemicals. We have already obtained cGMP in this line, and would like to provide you with the best products and services. We, NCPCR&D, as the original manufacturer of bulk pharmaceuticals and finish preparations in China, specilized in pharmaceutical chemicals and would like to introduce our main products to you.

Immunosuppressant group:
-cyclosporine A
-tacrolimus (FK506)
-sirolimus
-mycophenolate mofetil

Other bulk pharmaceutical:
-norvancomycin hydrochloride
-bacitracin zinc
-teicoplanin
-lovastatin
-pravastatin sodium

Finish preparation:
- cyclosporine A(oral solution, soft capsules, eye drops)
-sirolimus oral solution
-tacrolimus capsules
- norvancomycin hydrochloride lyophilized powder for injection
-amphotericin B lyophilized powder for injection
-monocycline hydrochloride capsules  
-ribovirin eye drops
-vitamin b12 eye drops
-lovastatin tablets
-pravastatin sodium tablets